Header Logo

Connection

Rami Doukky to Tomography, Emission-Computed, Single-Photon

Back to Details
This is a "connection" page, showing publications Rami Doukky has written about Tomography, Emission-Computed, Single-Photon.
Rami Doukky
Connection Strength
13.499
Tomography, Emission-Computed, Single-Photon
  1. The prognostic value of regadenoson SPECT myocardial perfusion imaging: The largest cohort to date. J Nucl Cardiol. 2021 12; 28(6):2799-2807.
    View in: PubMed
    Score: 0.659
  2. Assessment of myocardial viability using single-photon emission computed tomography myocardial perfusion imaging. Curr Opin Cardiol. 2019 09; 34(5):473-483.
    View in: PubMed
    Score: 0.629
  3. Prognostic value of regadenoson stress myocardial perfusion imaging in patients with left bundle branch block or ventricular paced rhythm. J Nucl Cardiol. 2021 06; 28(3):967-977.
    View in: PubMed
    Score: 0.618
  4. Deciding wisely: A case for an effective use of myocardial perfusion imaging. J Nucl Cardiol. 2018 02; 25(1):53-61.
    View in: PubMed
    Score: 0.557
  5. Regadenoson use in chronic kidney disease and end-stage renal disease: A focused review. J Nucl Cardiol. 2018 02; 25(1):137-149.
    View in: PubMed
    Score: 0.541
  6. Fully automated analysis of perfusion data: The rise of the machines. J Nucl Cardiol. 2018 08; 25(4):1361-1363.
    View in: PubMed
    Score: 0.534
  7. Impact of integrating heart rate response with perfusion imaging on the prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 10; 24(5):1666-1671.
    View in: PubMed
    Score: 0.502
  8. Impact of a regimented aminophylline administration protocol on the burden of regadenoson-induced ischemia detected by SPECT myocardial perfusion imaging. J Nucl Cardiol. 2017 10; 24(5):1571-1578.
    View in: PubMed
    Score: 0.501
  9. Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging. J Nucl Med. 2016 Aug; 57(8):1251-7.
    View in: PubMed
    Score: 0.498
  10. Appropriate use criteria for SPECT myocardial perfusion imaging: Are they appropriate for women? J Nucl Cardiol. 2016 08; 23(4):695-705.
    View in: PubMed
    Score: 0.476
  11. Impact of insurance carrier, prior authorization, and socioeconomic status on appropriate use of SPECT myocardial perfusion imaging in private community-based office practice. Clin Cardiol. 2015 May; 38(5):267-73.
    View in: PubMed
    Score: 0.466
  12. The significance of automatically measured transient ischemic dilation in identifying severe and extensive coronary artery disease in regadenoson, single-isotope technetium-99m myocardial perfusion SPECT. J Nucl Cardiol. 2015 Jun; 22(3):526-34.
    View in: PubMed
    Score: 0.463
  13. Prognostic implications of stress modality on mortality risk and cause of death in patients undergoing office-based SPECT myocardial perfusion imaging. J Nucl Cardiol. 2016 Apr; 23(2):202-11.
    View in: PubMed
    Score: 0.462
  14. Effective risk stratification of patients on the basis of myocardial perfusion SPECT is dependent on appropriate patient selection. Curr Cardiol Rep. 2015 Jan; 17(1):549.
    View in: PubMed
    Score: 0.455
  15. The impact of regimented aminophylline use on extracardiac radioisotope activity in patients undergoing regadenoson stress SPECT myocardial perfusion imaging: a substudy of the ASSUAGE trial. J Nucl Cardiol. 2014 Jun; 21(3):496-502.
    View in: PubMed
    Score: 0.428
  16. Impact of appropriate use on the prognostic value of single-photon emission computed tomography myocardial perfusion imaging. Circulation. 2013 Oct 08; 128(15):1634-43.
    View in: PubMed
    Score: 0.416
  17. The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: a cautionary note in patients with diabetes and coronary artery disease. J Nucl Cardiol. 2013 Oct; 20(5):774-84.
    View in: PubMed
    Score: 0.413
  18. The prognostic value of cardiac SPECT performed at the primary care physician's office. J Nucl Cardiol. 2013 Aug; 20(4):519-28.
    View in: PubMed
    Score: 0.401
  19. The safety and tolerability of regadenoson in patients with end-stage renal disease: the first prospective evaluation. J Nucl Cardiol. 2013 Apr; 20(2):205-13.
    View in: PubMed
    Score: 0.395
  20. Attenuation of the side effect profile of regadenoson: a randomized double-blind placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging and have severe chronic kidney disease--the ASSUAGE-CKD trial. Int J Cardiovasc Imaging. 2013 Jun; 29(5):1029-37.
    View in: PubMed
    Score: 0.395
  21. Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial". J Nucl Cardiol. 2012 Jun; 19(3):448-57.
    View in: PubMed
    Score: 0.374
  22. Soft tissue attenuation patterns in stress myocardial perfusion SPECT images: a comparison between supine and upright acquisition systems. J Nucl Cardiol. 2011 Apr; 18(2):281-90.
    View in: PubMed
    Score: 0.346
  23. Ambulatory cardiac single-photon emission computed tomography at the primary care physician's office: a descriptive study. J Ambul Care Manage. 2010 Oct-Dec; 33(4):328-35.
    View in: PubMed
    Score: 0.339
  24. ASNC SPECT-MPI quality metrics: a race to the top. J Nucl Cardiol. 2023 06; 30(3):911-914.
    View in: PubMed
    Score: 0.203
  25. Impact of change of ischemic burden on the outcomes of ESRD patients awaiting kidney transplantation. J Nucl Cardiol. 2023 10; 30(5):1897-1903.
    View in: PubMed
    Score: 0.203
  26. The prognostic and diagnostic implications of surveillance serial myocardial perfusion imaging in asymptomatic renal transplant candidates. J Nucl Cardiol. 2023 02; 30(1):152-163.
    View in: PubMed
    Score: 0.191
  27. The diagnostic and prognostic value of near-normal perfusion or borderline ischemia on stress myocardial perfusion imaging. J Nucl Cardiol. 2022 04; 29(2):826-835.
    View in: PubMed
    Score: 0.170
  28. The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging. J Nucl Cardiol. 2022 04; 29(2):810-821.
    View in: PubMed
    Score: 0.170
  29. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls. J Nucl Cardiol. 2021 02; 28(1):104-111.
    View in: PubMed
    Score: 0.169
  30. The prognostic utility of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease: The largest cohort to date. J Nucl Cardiol. 2022 Feb; 29(1):101-110.
    View in: PubMed
    Score: 0.167
  31. Artificial Intelligence in Nuclear Cardiology. J Nucl Med. 2019 Aug; 60(8):1042-1043.
    View in: PubMed
    Score: 0.153
  32. Coming-of-age: The ImageGuide? Registry at three. J Nucl Cardiol. 2019 02; 26(1):72-75.
    View in: PubMed
    Score: 0.147
  33. Prognostic significance of ischemic electrocardiographic changes with regadenoson stress myocardial perfusion imaging. J Nucl Cardiol. 2020 10; 27(5):1521-1532.
    View in: PubMed
    Score: 0.146
  34. Dual isotope stress Tl-201 and rest Tc-99m CZT SPECT: Are we truly leveraging CZT technology? J Nucl Cardiol. 2019 08; 26(4):1280-1283.
    View in: PubMed
    Score: 0.142
  35. The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation. J Nucl Cardiol. 2019 06; 26(3):814-822.
    View in: PubMed
    Score: 0.137
  36. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017 02; 24(1):112-118.
    View in: PubMed
    Score: 0.121
  37. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease. J Nucl Cardiol. 2016 06; 23(3):560-9.
    View in: PubMed
    Score: 0.119
  38. Outcomes after inappropriate nuclear myocardial perfusion imaging: A meta-analysis. J Nucl Cardiol. 2016 08; 23(4):680-9.
    View in: PubMed
    Score: 0.119
  39. Diagnostic and prognostic significance of ischemic electrocardiographic changes with regadenoson-stress myocardial perfusion imaging. J Nucl Cardiol. 2015 Aug; 22(4):700-13.
    View in: PubMed
    Score: 0.116
  40. Quality metrics for single-photon emission computed tomography myocardial perfusion imaging: an ASNC information statement. J Nucl Cardiol. 2023 04; 30(2):864-907.
    View in: PubMed
    Score: 0.050
  41. Multi-modality imaging: Bird's eye view from the 2018 American Heart Association Scientific Sessions. J Nucl Cardiol. 2019 04; 26(2):645-654.
    View in: PubMed
    Score: 0.038
  42. Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR. J Cardiovasc Magn Reson. 2018 12 20; 20(1):87.
    View in: PubMed
    Score: 0.037
  43. Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR. J Nucl Cardiol. 2019 Jun; 26(3):1007-1014.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.